BENYLIN ENERGY BOOSTING HERBAL LOZENGES DIN 02243735
Status: Cancelled Post Market
Holder: PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION
Molecule: SIBERIAN GINSENG
Health Canada record
| Active ingredient(s) | SIBERIAN GINSENG 240 MG |
|---|---|
| Dosage form | Lozenge |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | |
| Original market date | 08-Aug-2001 |
| Current status date | 05-Aug-2004 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SIBERIAN GINSENG
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02241355 | ETHICAL HERBALS SIBERIAN GINSENG ENERGY FORMULA | ASHBURY RESEARCH CORPORATION | Tablet | SIBERIAN GINSENG 1500 MG | Cancelled Pre Market |